or 2. Converting every individual into diabetic patient?
Of course they will be more powerful and economically viable if the world is full of diabetic patients. The day, diabetes is eliminated from the face of the earth, will automatically make them extinct as well. So, although reversing diabetes is just a matter of few days (as demonstrated in my documentary) but these organizations successfully keep the truth out of the reach of the masses as well as the medical syllabus.
It is the clear case of misleading education.
To make you understand, let me put a clear case of medical misunderstanding.
It is famously said that in case of Diabetes Type 1 patients, the beta cells have gotten killed and so the body has lost the ability to produce insulin and hence the Diabetes Type 1 patient has to remain dependent on the outside source of insulin throughout their life and there is no way they could reverse the disease.
This was what being communicated to one of my young patient’s father Mr.
Jagjeet by the American Diabetes Association through email.
The truth in case of Diabetes Type 1 patients is that, the beta cells become dormant and stop producing insulin. Upon giving the right surroundings these can recover and get into action of producing insulin. This required change in surrounding for the beta cells can be provided by appropriate changes in the diet and life style (as explained in the next chapter).
As it happened with Mr. Jagjeet Singh’s 9 yrs old son suffering from Diabetes Type 1. Within a week of their visit to my office they were forced to discard all kind of external insulin as the child’s body started producing its own insulin. The shocked and surprised parents referred to their Diabetologist Dr. Anju Virmani of Max Hospital to show the result of their son’s reversal
from Diabetes Type 1. Here the overmedicalized doctor dismissed the recovery as a temporary phase and tried to convince the parents with the scientific-unscientific jargon like honeymoon period.
The conventional diabetologists are being trained and taught lots of medical jargons to camouflage the real recovery from disease and label them as temporary and maintaining that the disease will again strike back.
They even criticize the patients who have adopted the new diet plan to reverse the disease even if the new diet plan is completely based on the medically proven results produced by their very own institution whom they consider as most reputed and of the highest authoritative value.
Here as a health researcher, my greatest challenge is to choose the unbiased scientific evidence among the thousands of research published in the reputed medical journals every year.
One way to achieve it is to eliminate those research outcomes which are being sponsored by pharmaceuticals companies as they are commercially driven to prove that the outcome supports their product as beneficial for the patients.
If you go one step further, you will realize that there is a good amount of confusion among various medical institutions themselves.
As it is evident from the experience of my patient Mr.
J.
K.
Paul, a supreme court advocate from Bangladesh.
One day he visited my office and said,” Doctor, whenever I visit India I am diagnosed with initial stage of diabetes whereas when I am back in Bangladesh, my blood glucose level is very much considered within the normal range!” To solve this riddle you have to go through the diagnostic parameters set by two authenticated bodies i.e., WHO and ADA.
In Bangladesh, the WHO parameters are followed majorly whereas in India ADA diagnostic parameters (which is more aggressive) are being followed.
Automatically more people will be diagnosed with diabetes as blood glucose range in case of ADA is narrower.
Similar is the condition of my another international patient Mr.
Vinay from Dubai who is suffering from cancer and is following our prescribed diet plan.
Although he has no symptomatic sign of the disease but remains confused because of the highly contradictory diagnostic outcomes between the results of the diagnosis in Dubai and the one when he visits India.
Similarly, lot of discrepancy can be found when patient is diagnosed for diabetes in Canada, then in UK and then USA.
This means, whether you are a patient of diabetes does not depend on you, but on
the place where you are being diagnosed!
In this confusion do you really feel that you can ever get cured?
This ambiguity makes the current medical science and its practice highly questionable.
Let’s take another simple example to make the point understandable.
During our 1 Day Diabetes Cure Initiation program, we requested all the participating patients to bring along their glucometers.
They were made to check their fasting blood sugar through Dr.
Lal Path Lab and simultaneously with their personal glucometer.
To everyone’s surprise the outcome of the blood sugar readings varied between 10% to 20% between the results of the Dr.
Lal Path Lab and their own personal glucometer and also it varied for the various brands.
For example, patients who had glucometer manufactured by Dr.
MorePen had 10% higher readings than the result provided by Dr.
Lal Path Lab whereas the patients with glucometer manufactured by Accu Chek had as much as 20% variation.
This field of diagnosis is full of assumptions, confusion and mystery.
One amazing case is the case of patients with mental illness.
A patient with a particular set of symptoms may be diagnosed as a patient of schizophrenia in USA whereas the same patient will be diagnosed as a patient of bipolar disease by a doctor in Britain and an Australian doctor will label him as a patient of depression.
This became evident during the launch of Diagnostic And Statistical Manual For Mental Disorder-5 (DSM-5 ) which was launched last year (22nd March, 2013).
It attracted controversy from various organizations dedicated to mental disorders including International Consortium of Human Genome.
The DSM which is considered to be the bible for psychiatrists across the world should have excluded the above mentioned discrepancy in the diagnosis of the mental disorder in their latest edition (DSM-5).
But that also meant all the previous knowledge, education and treatment protocol learnt by the psychiatrist would become almost obsolete, which would have been commercially highly unprofitable, even if it may mean higher benefits for the patients of mental disorder.
Just imagine the fate of the patient; understanding that the treatment protocol and medication in all the three are different and mutually exclusive. As a patient or a well wisher of a patient do you really think that you can depend on such uncertain parameters or for that matter such uncertain science! It’s more of a kind of hit and trial. May be that is the reason, doctors are called practicing doctors lifelong! Only time will tell, when the world will be clear
about the medical science and clearer about conventional, commercially driven medical science.
Let’s go back to our current subject” Diabetes”. Let’s try to understand the scientific looking popular diabetes 75 gm Oral Glucose Tolerance Test (OGTT). Imagine two diabetic patients with impaired fasting glucose say, at 170 mg/dl and are of same age (say 50 year) and both are males. But let’s assume patient A weighs 45 kg whereas patient B weighs 90 kg.
From the knowledge of the previous chapter it is clear that 75 gm of oral glucose intake in both the patients will metabolize differently depending on many factors including the amount of blood in the body.
The patient A may have roughly 4 litres of blood in his body whereas patient B has 6 litres of blood.
Surely the person with more circulating blood will have less burden of metabolizing the 75 gm of glucose and will be able to bring back the blood glucose to normal, sooner than the other patient imagining all other factors are constant.
As of result of such more or less unreliable diagnostic tools the unsuspecting patients get trapped in the needless cycle of diagnosis, medicine and hospital visits and end up spending on an average Rs. 50,000 yearly.
Now imagine, India is a country with second highest number of diabetic patients (6.5 crores - IDF 2014) .
It is this toxic marriage of science and commerce which has resulted in the health and wealth disaster in India.
Consider these three exclusive cases
Case 1 . In year 2009, the health minister conducted a massive diabetes diagnosis program covering more than 2 crore Indians nationally. To calculate the total economic burden of their needless gigantic project, you have to include the cost of glucometer, testing strips, training the volunteers, transportation and maintenance of records. It would be highly inconclusive.
Case 2 . Force feeding government school children across the country with iron and folic acid tablets has been one of the government’s favorite mass health project of the recent times even if it is being declared to be toxic and injurious to the school children’s health by the much respected Cochrane Database, 2011.
Can you imagine a fruit or a vegetable with just a single nutrient? Take an example of an orange. It is not just a source of Vitamin C. Along with it,
orange is packed with more than 100 varieties of nutrients including other vitamins, minerals, etc.
The arrangement of each nutrient surrounded by other nutrients plays an important role in the metabolism of each of the nutrient once they are in the body.
A single nutrient in isolation (as in the case of folic acid and iron tablets) may not be able to get absorbed by the body and will remain in the body as a toxic waste, clogging the system and resulting in a challenge for the body to maintain homeostasis.
To my understanding distributing and force feeding these unnecessary and toxic nutrient supplement among the government school children is an act of mass producing future diabetic and other associated illness’ patients and creating a market for profit driven pharmaceutical companies.
Case 3 .
Pioglitazone an antidiabetic drug is banned in many countries including France and Germany since 2011 as it leads to bladder cancer.
In India, government banned it on 12 June 2013 only to take a U-turn under the pressure of drug companies and suspended the ban on 31st July 2013.
At present in India there are more than 30 lakh consumers of the same drug, many of them are looking toward its expected side effects, i.e. the bladder cancer.
Clearly the health care system is not for patients, it is for profit.
You can well imagine the market size of the diabetes drug industry in India by considering the fact that per month sale of just one drug Metformin is around Rs. 100 crore (it was Rs. 104 crore in the month of May, 2014).
To understand how money can influence government decision making doctor’s understanding about the drug and its effect on the body by hiding the results of the adverse drug reaction. Consider the case of Rosglitazone which was first marketed in 1999 by GSK.
In 1999 Rosiglitazone was launched by GlaxoSmithKline.
Dr. John Bose from University of North Carolina reported about the increased risk of heart problems among the patients consuming Rosiglitazone.GlaxoSmithKline made a direct contact and silenced Dr. John Bose.
In 2003, Uppsula Drug Monitoring Group of WHO contacted GlaxoSmithKline with the reports of heart problem among the patients using Rosiglitazone.
GlaxoSmithKline carried a misleading and false claims about the safety profile of its diabetes drug Rosiglitazone, even suggesting there were cardiovascular benefits from the drug, whereas in reality even FDA label said there were cardiovascular risks.
Between 2006 and 2007 GlaxoSmithKline withheld the results of all the internal meta-analysis (which reconfirmed the cardiovascular risks for the patients) from FDA.